262 related articles for article (PubMed ID: 22926567)
21. Bactericidal activity does not predict sterilizing activity: the case of rifapentine in the murine model of Mycobacterium ulcerans disease.
Almeida DV; Converse PJ; Li SY; Tyagi S; Nuermberger EL; Grosset JH
PLoS Negl Trop Dis; 2013; 7(2):e2085. PubMed ID: 23469308
[TBL] [Abstract][Full Text] [Related]
22. Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis.
Gold B; Roberts J; Ling Y; Quezada LL; Glasheen J; Ballinger E; Somersan-Karakaya S; Warrier T; Warren JD; Nathan C
Antimicrob Agents Chemother; 2015 Oct; 59(10):6521-38. PubMed ID: 26239979
[TBL] [Abstract][Full Text] [Related]
23. Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169).
Lupien A; Vocat A; Foo CS; Blattes E; Gillon JY; Makarov V; Cole ST
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126954
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis.
Solapure S; Dinesh N; Shandil R; Ramachandran V; Sharma S; Bhattacharjee D; Ganguly S; Reddy J; Ahuja V; Panduga V; Parab M; Vishwas KG; Kumar N; Balganesh M; Balasubramanian V
Antimicrob Agents Chemother; 2013 Jun; 57(6):2506-10. PubMed ID: 23507276
[TBL] [Abstract][Full Text] [Related]
25. Action of fluoroquinolones and Linezolid on logarithmic- and stationary-phase culture of Mycobacterium tuberculosis.
García-Tapia A; Rodríguez JC; Ruiz M; Royo G
Chemotherapy; 2004 Nov; 50(5):211-3. PubMed ID: 15523179
[TBL] [Abstract][Full Text] [Related]
26. Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid.
Kim S; Louie A; Drusano GL; Almoslem M; Kim S; Myrick J; Nole J; Duncanson B; Peloquin CA; Scanga CA; Yamada W; Neely M; Schmidt S
Int J Antimicrob Agents; 2022 Feb; 59(2):106509. PubMed ID: 34958863
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the mycobacterium efficacy of linezolid in vitro].
Huang HR; Yu X; Jiang GL; Dai GM; Bi ZQ; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Aug; 34(8):575-8. PubMed ID: 22168977
[TBL] [Abstract][Full Text] [Related]
28. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
Taneja NK; Tyagi JS
J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
[TBL] [Abstract][Full Text] [Related]
29. Interaction between linezolid and Mycobacterium tuberculosis in an experimental in vitro model.
Cremades R; Rodríguez JC; Garcia-Pachón E; Galiana A; Ruiz-García M; López P; Royo G
APMIS; 2011 Apr; 119(4-5):304-8. PubMed ID: 21492231
[TBL] [Abstract][Full Text] [Related]
30. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
Devi PB; Sridevi JP; Kakan SS; Saxena S; Jeankumar VU; Soni V; Anantaraju HS; Yogeeswari P; Sriram D
Tuberculosis (Edinb); 2015 Dec; 95(6):786-794. PubMed ID: 26299907
[TBL] [Abstract][Full Text] [Related]
31. Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice.
Almeida D; Converse PJ; Ahmad Z; Dooley KE; Nuermberger EL; Grosset JH
PLoS Negl Trop Dis; 2011 Jan; 5(1):e933. PubMed ID: 21245920
[TBL] [Abstract][Full Text] [Related]
32. In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates.
Chandramohan Y; Padmanaban V; Bethunaickan R; Tripathy S; Swaminathan S; Ranganathan UD
J Glob Antimicrob Resist; 2019 Dec; 19():348-353. PubMed ID: 31226332
[TBL] [Abstract][Full Text] [Related]
33. Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.
Wallis RS; Jakubiec W; Mitton-Fry M; Ladutko L; Campbell S; Paige D; Silvia A; Miller PF
PLoS One; 2012; 7(1):e30479. PubMed ID: 22279595
[TBL] [Abstract][Full Text] [Related]
34. Bactericidal potencies of new regimens are not predictive of their sterilizing potencies in a murine model of tuberculosis.
Andries K; Gevers T; Lounis N
Antimicrob Agents Chemother; 2010 Nov; 54(11):4540-4. PubMed ID: 20713662
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
36. Post-antibiotic effects of linezolid and other agents against Mycobacterium tuberculosis.
Hui M; Au-Yeang C; Wong KT; Chan CY; Yew WW; Leung CC
Int J Antimicrob Agents; 2008 Apr; 31(4):395-6. PubMed ID: 18272351
[No Abstract] [Full Text] [Related]
37. In vitro combination studies of benzothiazinone lead compound BTZ043 against Mycobacterium tuberculosis.
Lechartier B; Hartkoorn RC; Cole ST
Antimicrob Agents Chemother; 2012 Nov; 56(11):5790-3. PubMed ID: 22926573
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics of TMC207 and its N-desmethyl metabolite in a murine model of tuberculosis.
Rouan MC; Lounis N; Gevers T; Dillen L; Gilissen R; Raoof A; Andries K
Antimicrob Agents Chemother; 2012 Mar; 56(3):1444-51. PubMed ID: 22155815
[TBL] [Abstract][Full Text] [Related]
39. Activity of drug combinations against dormant Mycobacterium tuberculosis.
Filippini P; Iona E; Piccaro G; Peyron P; Neyrolles O; Fattorini L
Antimicrob Agents Chemother; 2010 Jun; 54(6):2712-5. PubMed ID: 20350948
[TBL] [Abstract][Full Text] [Related]
40. In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants.
Ismail N; Omar SV; Ismail NA; Peters RPH
J Microbiol Methods; 2018 Oct; 153():1-9. PubMed ID: 30165087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]